GO:0072133 metanephric mesenchyme morphogenesis: Kidney Development Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0072133 metanephric mesenchyme morphogenesis describes how the loose mesenchymal tissue of the metanephros organizes into the anatomical structures that seed the permanent kidney.
• The process is initiated by signals from the ureteric bud, which induces metanephric mesenchyme condensation, a prerequisite for epithelialization and nephron formation.
• Key regulators include SIX1, which controls GREM1 expression in the metanephric mesenchyme to drive branching morphogenesis, and nonmuscle myosin II, which governs immature nephron morphogenesis.
• Disruption of metanephric mesenchyme morphogenesis is linked to congenital anomalies of the kidney and urinary tract (CAKUT) and renal agenesis phenotypes.
• Human pluripotent stem cell-derived kidney organoids and ureteric bud organoids provide tractable models to study this process in vitro.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of candidate genes in metanephric mesenchyme morphogenesis.
Description
Metanephric mesenchyme morphogenesis (GO:0072133) is the biological process in which the anatomical structures of metanephric mesenchymal tissue are generated and organized. The metanephric mesenchyme is the loosely connected mesenchymal cell population within the metanephros, the embryonic structure that gives rise to the permanent kidney. Understanding this process is central to developmental biology because it represents the earliest morphogenetic step that commits mesenchyme to nephron-forming lineages. Experimental evidence shows that signals from the ureteric bud induce metanephric mesenchyme condensation, a compacting event that precedes epithelialization and subsequent nephron segmentation. Isthmin-1 has been identified as a critical regulator of branching morphogenesis and metanephric mesenchyme condensation during early kidney development. In parallel, SIX1 regulates GREM1 expression in the metanephric mesenchyme to initiate branching morphogenesis, linking transcriptional control to tissue-level morphogenesis. Nonmuscle myosin II activity is required for the morphogenesis of metanephric mesenchyme-derived immature nephrons, highlighting the cytoskeletal basis of this process. For researchers, GO:0072133 provides a precise annotation target for functional genomics, organoid engineering, and disease modeling of congenital kidney anomalies. Because the process is conserved and can be partially recapitulated in human pluripotent stem cell-derived organoids, it is an attractive system for CRISPR screening and mechanistic studies.
metanephric mesenchyme morphogenesis At A Glance
| GO ID | GO:0072133 |
|---|---|
| GO term | metanephric mesenchyme morphogenesis |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Generation and organization of anatomical structures in metanephric mesenchymal tissue |
| Tissue context | Metanephric mesenchyme, the loosely connected mesenchymal cells of the metanephros |
| Key initiating event | Ureteric bud-induced mesenchymal condensation and branching morphogenesis |
| Cytoskeletal basis | Nonmuscle myosin II-dependent morphogenesis of immature nephrons |
| Disease relevance | Congenital anomalies of the kidney and urinary tract (CAKUT) and renal agenesis |
| Model systems | Human pluripotent stem cell-derived kidney organoids and ureteric bud organoids |
What Is GO:0072133?
In simple terms, GO:0072133 metanephric mesenchyme morphogenesis is the set of cellular and tissue-level events that shape the loose mesenchymal tissue of the metanephros into organized anatomical structures. According to the QuickGO definition, it is the process in which the anatomical structures of a metanephric mesenchymal tissue are generated and organized, where metanephric mesenchyme is the tissue made up of loosely connected mesenchymal cells in the metanephros. This process includes mesenchymal condensation, cell rearrangement, and the morphogenetic transitions that prepare mesenchyme-derived cells for nephron formation.
Why Is metanephric mesenchyme morphogenesis Important in Cell Biology?
GO:0072133 metanephric mesenchyme morphogenesis is important because it defines the earliest tissue-level events that determine whether a functional kidney will form. Defects in this process are associated with renal agenesis and congenital anomalies of the kidney and urinary tract, making it a direct target for understanding developmental kidney disease. The process also serves as a paradigm for how mesenchymal tissues are induced, condensed, and reorganized by neighboring epithelial signals, with SIX1-GREM1 and isthmin-1 representing key regulatory nodes. Because human pluripotent stem cell-derived organoids can recapitulate aspects of metanephric mesenchyme morphogenesis, the term is increasingly relevant to regenerative medicine and disease modeling. Finally, the cytoskeletal control of immature nephron morphogenesis by nonmuscle myosin II illustrates how cell mechanics intersect with organogenesis.
• Defines the earliest morphogenetic step that commits metanephric mesenchyme to nephron-forming lineages.
• Provides a mechanistic framework for ureteric bud-induced mesenchymal condensation and branching morphogenesis.
• Links transcriptional regulators such as SIX1 to GREM1-dependent initiation of branching morphogenesis.
• Implicates cytoskeletal machinery, including nonmuscle myosin II, in immature nephron morphogenesis.
• Underlies congenital anomalies of the kidney and urinary tract and renal agenesis phenotypes.
• Supports human pluripotent stem cell-based kidney organoid engineering and disease modeling.
• Enables CRISPR knockout, knock-in, and overexpression studies of candidate morphogenesis genes.
• Provides a benchmark for developmental hypoxia and organoid complexity studies.
• Connects developmental biology to regenerative nephrology and drug discovery.
• Offers a conserved process for comparative studies of ureteric bud and collecting duct development.
What Happens During metanephric mesenchyme morphogenesis?
Ureteric bud induction and mesenchymal condensation
In simple terms: The growing ureteric bud sends signals that make the loose mesenchyme pack together.
Metanephric mesenchyme morphogenesis begins when the ureteric bud invades the metanephric mesenchyme and induces condensation of loosely connected mesenchymal cells. Isthmin-1 has been identified as a critical regulator of branching morphogenesis and metanephric mesenchyme condensation during early kidney development. SIX1 regulates GREM1 expression in the metanephric mesenchyme to initiate branching morphogenesis, linking transcriptional control to the earliest morphogenetic events. This condensation step is a prerequisite for subsequent epithelialization and nephron formation.
Cytoskeletal remodeling and immature nephron morphogenesis
In simple terms: The cells change shape and move using their internal skeleton to form early nephron structures.
Nonmuscle myosin II regulates the morphogenesis of metanephric mesenchyme-derived immature nephrons, demonstrating that actomyosin contractility is required for shaping mesenchymal derivatives. This cytoskeletal activity supports the cell rearrangements and shape changes that accompany the transition from condensed mesenchyme to immature nephron structures. The process is therefore not only a signaling event but also a mechanical one, in which forces generated by the cytoskeleton organize the tissue.
Integration with ureteric bud and collecting system development
In simple terms: The mesenchyme and the ureteric bud must coordinate so the kidney's filtering and collecting parts connect.
Metanephric mesenchyme morphogenesis occurs in close coordination with ureteric bud development, and the ureteric bud can develop into the ureter even in the absence of a kidney collecting system. Human pluripotent stem cell-derived ureteric bud and collecting duct organoids provide a tractable system to study this coordination. Integrating collecting systems in human kidney organoids through fusion of distal nephron to ureteric bud further demonstrates the importance of mesenchyme-ureteric bud interaction.
Organoid modeling of metanephric mesenchyme morphogenesis
In simple terms: Scientists grow miniature kidney-like tissues in the lab to watch this process happen.
Kidney organoids and tubuloids have been developed as models to study kidney development and disease, including metanephric mesenchyme-derived structures. Directed differentiation of ureteric bud and collecting duct organoids from human pluripotent stem cells enables controlled investigation of the signaling environment that drives metanephric mesenchyme morphogenesis. Developmental hypoxia enhances kidney organoid complexity and maturity, indicating that environmental factors modulate this morphogenetic process.
Disease-relevant disruption of metanephric mesenchyme morphogenesis
In simple terms: When this process goes wrong, the kidney can fail to form properly.
Disruption of metanephric mesenchyme morphogenesis is linked to congenital anomalies of the kidney and urinary tract and renal agenesis phenotypes. Because the process depends on regulators such as isthmin-1 and SIX1-GREM1 signaling, perturbations in these pathways can impair mesenchymal condensation and branching morphogenesis. Organoid and animal models allow researchers to test how specific genetic lesions alter metanephric mesenchyme morphogenesis and downstream nephron formation.
Key Genes Involved in GO:0072133 metanephric mesenchyme morphogenesis
The following genes and proteins have been experimentally implicated in metanephric mesenchyme morphogenesis or in closely related early kidney developmental processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SIX1 | Regulates GREM1 expression in the metanephric mesenchyme to initiate branching morphogenesis | Transcription factor node for mesenchymal induction and branching |
| GREM1 | Target of SIX1 in the metanephric mesenchyme; modulates BMP signaling during branching morphogenesis | Secreted BMP antagonist linked to mesenchymal signaling |
| ISTHMIN-1 (ISM1) | Critical regulator of branching morphogenesis and metanephric mesenchyme condensation | Secreted factor controlling early mesenchymal condensation |
| Nonmuscle myosin II (MYH9/MYH10) | Regulates morphogenesis of metanephric mesenchyme-derived immature nephrons | Cytoskeletal motor required for nephron morphogenesis |
| GDNF | Signaling factor in ureteric bud induction and mesenchymal-epithelial crosstalk | Classic inducer of ureteric bud branching |
| WT1 | Transcription factor in metanephric mesenchyme and nephron progenitors | Marker and regulator of mesenchymal identity |
| PAX2 | Transcription factor in metanephric mesenchyme and ureteric bud lineages | Lineage specification and organoid differentiation |
| PAX8 | Transcription factor in kidney and ureteric bud development | Collecting system and organoid differentiation |
| SALL1 | Transcription factor in metanephric mesenchyme and nephron progenitors | Mesenchymal progenitor maintenance |
| EYA1 | Coactivator in renal progenitor and ureteric bud development | Branching morphogenesis and organoid formation |
| HOXD11 | Transcription factor in metanephric mesenchyme and kidney patterning | Regional patterning of the metanephros |
| BMP4 | Signaling factor modulating mesenchymal condensation and branching | Pathway node for morphogenesis control |
| FGF8 | Signaling factor in metanephric mesenchyme and early kidney development | Growth factor input to condensation |
| WNT9B | Ureteric bud-derived signal that induces metanephric mesenchyme | Epithelial-to-mesenchymal inductive signal |
| WNT4 | Mesenchymal signal required for epithelialization and nephron formation | Mesenchymal-to-epithelial transition regulator |
| LHX1 | Transcription factor in metanephric mesenchyme and nephron progenitors | Lineage commitment and morphogenesis |
| OSR1 | Transcription factor in intermediate mesoderm and metanephric mesenchyme | Early kidney progenitor specification |
| HNF1B | Transcription factor in ureteric bud and collecting duct development | Collecting system integration and organoid modeling |
How Is metanephric mesenchyme morphogenesis Regulated?
Metanephric mesenchyme morphogenesis is regulated by a combination of secreted signals and transcriptional programs. SIX1 controls GREM1 expression in the metanephric mesenchyme to initiate branching morphogenesis, placing transcriptional regulation upstream of mesenchymal condensation. Isthmin-1 acts as a critical regulator of branching morphogenesis and metanephric mesenchyme condensation during early kidney development. Nonmuscle myosin II provides cytoskeletal regulation of the morphogenesis of metanephric mesenchyme-derived immature nephrons. Environmental factors such as developmental hypoxia can enhance kidney organoid complexity and maturity, indicating that oxygen tension modulates this process. Together, these layers of regulation ensure that mesenchymal condensation, branching, and nephron formation are coordinated with ureteric bud development.
metanephric mesenchyme morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SIX1 | CAKUT and branching morphogenesis defects | Knockout and point-mutation organoids |
| GREM1 | Impaired mesenchymal condensation and branching | Overexpression and knockout models |
| ISTHMIN-1 (ISM1) | Defective metanephric mesenchyme condensation | Knockout and knock-in organoids |
| Nonmuscle myosin II (MYH9/MYH10) | Abnormal immature nephron morphogenesis | Point-mutation and knockout models |
| HNF1B | Collecting system and kidney developmental anomalies | Knock-in and organoid fusion models |
Congenital anomalies of the kidney and urinary tract (CAKUT)
Disruption of metanephric mesenchyme morphogenesis is linked to congenital anomalies of the kidney and urinary tract, including renal agenesis phenotypes. Because the process depends on regulators such as isthmin-1 and SIX1-GREM1 signaling, perturbations in these pathways can impair mesenchymal condensation and branching morphogenesis. Organoid and animal models allow researchers to test how specific genetic lesions alter metanephric mesenchyme morphogenesis and downstream nephron formation.
Renal agenesis and hypoplasia
Failure of metanephric mesenchyme morphogenesis can result in renal agenesis or hypoplasia, as the mesenchyme fails to condense and epithelialize properly. The ureteric bud can develop into the ureter even in the absence of a kidney collecting system, indicating that some aspects of ureteric development are independent of mesenchymal morphogenesis. This dissociation is important for understanding the spectrum of CAKUT phenotypes.
Organoid-based disease modeling
Human pluripotent stem cell-derived kidney organoids and ureteric bud organoids enable modeling of metanephric mesenchyme morphogenesis defects in vitro. Integrating collecting systems in human kidney organoids through fusion of distal nephron to ureteric bud improves the physiological relevance of these models. Developmental hypoxia enhances kidney organoid complexity and maturity, providing a tool to study environmental modifiers of morphogenesis.
From metanephric mesenchyme morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for metanephric mesenchyme condensation? | CRISPR knockout in human pluripotent stem cell-derived kidney organoids |
| Does a specific missense variant impair mesenchymal morphogenesis? | Point-mutation knock-in in organoids or cell lines |
| Can a disease-associated allele be corrected? | Knock-in of wild-type sequence and rescue assays |
| Where and when is a protein expressed during morphogenesis? | Tagged knock-in with fluorescent or epitope tags |
| Does overexpression of a factor enhance condensation? | Overexpression models in organoids and mesenchymal cells |
| Which genes modify branching morphogenesis? | CRISPR library screening in organoid and cell models |
How to Study the metanephric mesenchyme morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Kidney organoid differentiation | Formation of metanephric mesenchyme-derived structures | Modeling morphogenesis in vitro |
| Ureteric bud organoid culture | Branching and collecting duct development | Studying mesenchyme-ureteric bud interaction |
| Immunofluorescence imaging | Protein localization and tissue architecture | Tracking condensation and nephron formation |
| Transcriptomic profiling | Gene expression changes during morphogenesis | Identifying regulatory networks |
| CRISPR knockout | Loss-of-function effects on morphogenesis | Testing candidate gene requirement |
| Point-mutation knock-in | Effect of specific variants | Modeling disease-associated alleles |
| Overexpression assays | Gain-of-function effects on condensation | Testing sufficiency of regulators |
| Developmental hypoxia modulation | Organoid complexity and maturity | Studying environmental modifiers |
Organoid-based morphogenesis assays
Directed differentiation of ureteric bud and collecting duct organoids from human pluripotent stem cells enables controlled investigation of the signaling environment that drives metanephric mesenchyme morphogenesis. Integrating collecting systems in human kidney organoids through fusion of distal nephron to ureteric bud improves the physiological relevance of these models. Kidney organoids and tubuloids have been developed as models to study kidney development and disease, including metanephric mesenchyme-derived structures.
Transcriptomic and imaging readouts
Developmental hypoxia enhances kidney organoid complexity and maturity, indicating that environmental factors modulate this morphogenetic process. Imaging of organoid and animal models allows researchers to track mesenchymal condensation and nephron formation over time. Transcriptomic profiling of organoids and mesenchymal cells can identify gene expression changes associated with morphogenesis.
Genetic perturbation and functional validation
Nonmuscle myosin II regulates the morphogenesis of metanephric mesenchyme-derived immature nephrons, demonstrating that actomyosin contractility is required for shaping mesenchymal derivatives. SIX1 regulates GREM1 expression in the metanephric mesenchyme to initiate branching morphogenesis, linking transcriptional control to the earliest morphogenetic events. Isthmin-1 has been identified as a critical regulator of branching morphogenesis and metanephric mesenchyme condensation during early kidney development.
Comparative and developmental models
The ureteric bud can develop into the ureter even in the absence of a kidney collecting system, indicating that some aspects of ureteric development are independent of mesenchymal morphogenesis. This dissociation is important for understanding the spectrum of CAKUT phenotypes. Human pluripotent stem cell-derived ureteric bud and collecting duct organoids provide a tractable system to study this coordination.
How CRISPR Can Be Used to Study GO:0072133 metanephric mesenchyme morphogenesis
Knockout
CRISPR knockout in human pluripotent stem cell-derived kidney organoids enables testing whether a candidate gene is required for metanephric mesenchyme morphogenesis. Loss-of-function studies of regulators such as SIX1 and isthmin-1 can reveal defects in mesenchymal condensation and branching morphogenesis. Knockout of cytoskeletal genes such as nonmuscle myosin II can reveal requirements for immature nephron morphogenesis.
Point Mutation
Point-mutation knock-in allows modeling of disease-associated missense variants in genes linked to metanephric mesenchyme morphogenesis. Such models can distinguish loss-of-function from dominant-negative or gain-of-function effects. They are particularly useful for variants identified in CAKUT patients.
Knock-in
Knock-in of fluorescent or epitope tags enables visualization of proteins during metanephric mesenchyme morphogenesis. Knock-in of wild-type sequences can rescue phenotypes caused by disease alleles. Integrating collecting systems in human kidney organoids through fusion of distal nephron to ureteric bud can be combined with knock-in strategies to study morphogenesis.
Overexpression
Overexpression models test whether a factor is sufficient to enhance or alter metanephric mesenchyme morphogenesis. Overexpression of isthmin-1 or GREM1 can modulate condensation and branching in organoid and cell models. Developmental hypoxia enhances kidney organoid complexity and maturity, providing a complementary environmental perturbation.
How EDITGENE Supports metanephric mesenchyme morphogenesis Research
Researchers studying metanephric mesenchyme morphogenesis-related genes often need to determine whether a candidate gene is causally involved in mesenchymal condensation, branching, or nephron formation. EDITGENE provides CRISPR-based cell model services that enable precise, reproducible testing of these hypotheses in relevant cellular and organoid contexts.
Contact EDITGENE today to design your custom CRISPR model for metanephric mesenchyme morphogenesis research.
Frequently Asked Questions About metanephric mesenchyme morphogenesis
What is metanephric mesenchyme morphogenesis?
Metanephric mesenchyme morphogenesis (GO:0072133) is the process in which the anatomical structures of a metanephric mesenchymal tissue are generated and organized, where metanephric mesenchyme is the tissue made up of loosely connected mesenchymal cells in the metanephros.
What genes are involved in metanephric mesenchyme morphogenesis?
Key genes include SIX1, which regulates GREM1 expression to initiate branching morphogenesis, isthmin-1, a critical regulator of condensation, and nonmuscle myosin II, which controls immature nephron morphogenesis.
Why is metanephric mesenchyme morphogenesis important?
It defines the earliest tissue-level events that determine whether a functional kidney will form, and its disruption is linked to congenital anomalies of the kidney and urinary tract and renal agenesis.
How is metanephric mesenchyme morphogenesis studied?
It is studied using human pluripotent stem cell-derived kidney organoids, ureteric bud organoids, imaging, transcriptomics, and CRISPR-based genetic perturbation.
What is the role of SIX1 in metanephric mesenchyme morphogenesis?
SIX1 regulates GREM1 expression in the metanephric mesenchyme to initiate branching morphogenesis, linking transcriptional control to the earliest morphogenetic events.
What is the role of isthmin-1 in kidney development?
Isthmin-1 is a critical regulator of branching morphogenesis and metanephric mesenchyme condensation during early kidney development.
How does nonmuscle myosin II affect kidney morphogenesis?
Nonmuscle myosin II regulates the morphogenesis of metanephric mesenchyme-derived immature nephrons, demonstrating that actomyosin contractility is required for shaping mesenchymal derivatives.
Can kidney organoids model metanephric mesenchyme morphogenesis?
Yes, human pluripotent stem cell-derived kidney organoids and ureteric bud organoids can recapitulate aspects of metanephric mesenchyme morphogenesis and are used for disease modeling.
What diseases are linked to defects in metanephric mesenchyme morphogenesis?
Defects are linked to congenital anomalies of the kidney and urinary tract, renal agenesis, and hypoplasia.
How can CRISPR be used to study metanephric mesenchyme morphogenesis?
CRISPR knockout, point-mutation knock-in, knock-in, and overexpression models enable causal testing of candidate genes in organoid and cell-based assays.
Conclusion
GO:0072133 metanephric mesenchyme morphogenesis captures the essential early events that shape the mesenchymal tissue of the metanephros into structures competent for nephron formation. Experimental evidence implicates SIX1-GREM1 signaling, isthmin-1, and nonmuscle myosin II in mesenchymal condensation, branching, and immature nephron morphogenesis. Human pluripotent stem cell-derived organoids and CRISPR-based models provide powerful platforms to dissect these mechanisms and their links to congenital kidney disease. Continued research using these tools will refine our understanding of metanephric mesenchyme morphogenesis and support the development of regenerative and therapeutic strategies.
References
- 1. Shi M et al.. 2023. Directed differentiation of ureteric bud and collecting duct organoids from human pluripotent stem cells.. Nat Protoc 18(8):2485-2508 PMID: 37460630
- 2. Gao G et al.. 2024. Isthmin-1: A critical regulator of branching morphogenesis and metanephric mesenchyme condensation during early kidney development.. Bioessays 46(3):e2300189 PMID: 38161234
- 3. Shi M et al.. 2025. Integrating collecting systems in human kidney organoids through fusion of distal nephron to ureteric bud.. Cell Stem Cell 32(7):1055-1070.e8 PMID: 40345193
- 4. Bush KT et al.. 2006. Development and differentiation of the ureteric bud into the ureter in the absence of a kidney collecting system.. Dev Biol 298(2):571-84 PMID: 16934795
- 5. Recuenco MC et al.. 2015. Nonmuscle Myosin II Regulates the Morphogenesis of Metanephric Mesenchyme-Derived Immature Nephrons.. J Am Soc Nephrol 26(5):1081-91 PMID: 25168025
- 6. Yousef Yengej FA et al.. 2020. Kidney Organoids and Tubuloids.. Cells 9(6) PMID: 32466429
- 7. Nie X et al.. 2011. Six1 regulates Grem1 expression in the metanephric mesenchyme to initiate branching morphogenesis.. Dev Biol 352(1):141-51 PMID: 21281623
- 8. Lim H et al.. 2025. Developmental Hypoxia Enhances Kidney Organoid Complexity and Maturity.. Adv Sci (Weinh) 12(40):e01661 PMID: 40841925
